Ultivue Investors

19 investors on Angel Roster list Ultivue in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, China and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Ultivue can appear together.

Investors listed
19
With verified email
32%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 19 Ultivue investors

The most complete profiles first. Showing 19 of 19.

  • Carol SuhVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • David CruikshankVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHardware

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Sean KendallVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareEnterprise SoftwareEnergyChemical

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • John ZhuVerified

    Venture Capital · China

    Health CareWomen FoundedBiotechnologyHealth Diagnostics

    Portfolio: GKHT Medical Technology, Helian Health, Forerunner Medical, Medeor Therapeutics and 27 more

    Contact details available

  • Mark McDonnellVerified

    Venture Capital · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Shaan GandhiVerified

    Venture Capital · United States

    Health CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Verified email available

  • Tom BrennanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Connor McDermott

    Venture Capital, Investor · United States

    SeedHealth CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Contact details available

  • Corey Ritter

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceRoboticsManufacturing

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Nilay Thakar

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Rebecca Zhu

    Venture Capital, Investor · China

    SeedHealth CareWomen FoundedManufacturingBiotechnology

    Portfolio: GKHT Medical Technology, Helian Health, Forerunner Medical, Medeor Therapeutics and 27 more

    Contact details available

  • Sharon Kedar, CFA

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Contact details available

  • Steve Gillis

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more

    Contact details available

  • Mike Rubin, MD, PhD, CFA

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Contact details available

  • Patrick Smerkers

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Contact details available

  • Robert Nelsen

    Venture Capital, Investor · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more

    Contact details available

  • Samantha Shalom

    Venture Capital · United States

    Health CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Contact details available

  • Adam Wieschhaus, Ph.D., CFA

    Venture Capital, Investor · United States

    SeedBiotechnology

    Portfolio: Vestaron, Torus Biosystems, Isolere Bio, Kytopen and 2 more

    Contact details available

  • Hansjoerg Wyss

    Angel/Individual

    SeedHealth CareManufacturingMedicalSales

    Portfolio: Ultivue, Lenoss Medical

    Contact details available

Frequently asked questions

How many Ultivue investors are on Angel Roster?

Angel Roster lists 19 Ultivue investors. 6 of them (32%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (18), Private Equity Firms (7) and Founder-Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Ultivue investors invest in?

Among those that list a stage, the most common are Series B (6) and Seed (5).

Where are Ultivue investors based?

Most are based in the United States (15), China (2) and the United Kingdom (1).

Which companies have Ultivue investors backed?

The most-backed portfolio companies among them are Vizgen (15), Encodia (15), HiberCell (11), Hua Medicine (11) and AnchorDx (11).

How do I contact Ultivue investors?

Create a free Angel Roster account to search and filter all 19, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.